Institution
Huntsman Cancer Institute
Also known as: Huntsman Cancer Center · Huntsman Cancer Center - University of Utah Health · Huntsman Cancer Institute - University of Utah · Huntsman Cancer Institute at the University of Utah · Huntsman Cancer Institute at the University of Utah Health Sciences Center · Huntsman Cancer Institute of the University of Utah
- 465running trials
- 145closed trials
- 14,435publications (OpenAlex)
Running trials
Recruiting
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Not yet recruiting
Pre-Transplant Nutrition Counseling in Patients With Multiple Myeloma
Not yet recruiting
Recruiting
Not yet recruiting
LLM Intervention for Tobacco in Underserved Populations (LIFT-UP)
Not yet recruiting
Enrolling by invitation
Regional Efforts to Advance School-based Sun Safety Through Collaboration for Skin Health
Not yet recruiting
Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
Not yet recruiting
Phase IIA Study of Belzutifan in EPAS1-, EGLN1-, or VHL-Mutant Erythrocytosis
Recruiting
Recruiting
Recruiting
Recruiting
Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis
Recruiting
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Recruiting
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Recruiting
Recruiting
Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)
Recruiting
Recruiting
Recruiting
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
Recruiting
Recruiting
Recruiting
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Recruiting
Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Recruiting
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Recruiting
Recruiting
Recruiting
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Recruiting
Recruiting
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
Showing 50 of 465.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer30 recruiting
- Colorectal cancer20 recruiting
- Multiple myeloma20 recruiting
- Melanoma16 recruiting
- Pancreatic cancer16 recruiting
- Childhood cancers14 recruiting
- Myeloproliferative neoplasms14 recruiting
- Acute myeloid leukaemia13 recruiting
- Prostate cancer13 recruiting
- Bladder cancer12 recruiting
- Diffuse large B-cell lymphoma12 recruiting
- Chronic lymphocytic leukaemia10 recruiting
- Endometrial cancer10 recruiting
- Head and neck cancer10 recruiting
- Triple-negative breast cancer10 recruiting
- Ovarian cancer9 recruiting
- Follicular lymphoma8 recruiting
- Gastric and oesophageal cancer8 recruiting
- Glioblastoma7 recruiting
- Neuroendocrine tumours7 recruiting
- Sarcoma7 recruiting
- Acute lymphoblastic leukaemia6 recruiting
- Cervical cancer6 recruiting
- Metastatic breast cancer6 recruiting
- Myelodysplastic syndromes6 recruiting
- Liver and biliary tract cancer5 recruiting
- Chronic myeloid leukaemia4 recruiting
- Mantle cell lymphoma4 recruiting
- Brain metastases3 recruiting
- HIV3 recruiting
- Kidney cancer2 recruiting
- Thyroid cancer2 recruiting
- Amyloidosis1 recruiting
- Aplastic anaemia1 recruiting
- Haemophagocytic lymphohistiocytosis1 recruiting
- High blood pressure1 recruiting
- Meningioma1 recruiting
- Mesothelioma1 recruiting
- Obesity1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Stroke1 recruiting
Closed trials
Terminated
A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
Completed
Terminated
Completed
Completed
Completed
Terminated
Terminated
Terminated
Completed
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Terminated
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
Completed
Terminated
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Completed
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Terminated
Terminated
Terminated
Completed
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Completed
Completed
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
Terminated
Terminated
Terminated
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Terminated
Completed
Completed
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Completed
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Terminated
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Completed
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
Terminated
Withdrawn
CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)
Terminated
Terminated
Terminated
Terminated
[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial
Completed
Terminated
Terminated
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
Completed
Showing 50 of 145.
Registry name variants (45)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah 84112
335 trials
Huntsman Cancer Institute
Salt Lake City, Utah 84112
139 trials
University of Utah - Huntsman Cancer Institute
Salt Lake City, Utah 84112
49 trials
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah 84112
29 trials
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah 84112
22 trials
Huntsman Cancer Institute Univ of Utah
Salt Lake City, Utah 19026
4 trials
Huntsman Cancer Institute (The University of Utah)
Salt Lake City, Utah 84112
3 trials
Contact: Professor John Hynstrom
Huntsman Cancer Center
Salt Lake City, Utah 84112
2 trials
University of Utah Huntsman Cancer Institute (HCI)
Salt Lake City, Utah 84112
2 trials
NCT06804837Implement and Test Visual Consent Template and Process
NCT05958316Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Contact: Lauri Linder
University of Utah - Huntsman Cancer Institute - PPDS
Salt Lake City, Utah 84112-5550
2 trials
NCT06093672Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Contact: Maurizio Caserini
Contact: Adele De MASSON, clinical development director, MD, PhD
Huntsman Cancer Institute, 2000 Circle of Hope Drive
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute and University of Utah
Salt Lake City, Utah 84112
1 trial
NCT05552755Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Contact: Tavia Dutson
Huntsman Cancer Institute At The Univ. Of Utah
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute (HCI), University of Utah
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112-5500
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112-5500
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute in University of Utah
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute - Oncology Division
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute (Site 0002)
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute (Site 0037)
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute (Site 0042)
Salt Lake City, Utah 84112-5500
1 trial
Huntsman Cancer Institute (Site 1041)
Salt Lake City, Utah 84112-5500
1 trial
Huntsman Cancer Institute (Site 1532)
Salt Lake City, Utah 84112
1 trial
Huntsman Cancer Institute (Site 5041)
Salt Lake City, Utah 84112-5550
1 trial
Huntsman Cancer Institute, University of Utah,1280 E. Stringham Avenue
Salt Lake City, Utah 84106
1 trial
Huntsman Cancer Institute, University of Utah,165 North University Avenue
Farmington, Utah 84025
1 trial
Huntsman Cancer Institute, University of Utah 2000 Circle of Hope
Salt Lake City, UT, Utah 84112
1 trial
NCT03567889Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Contact: John Hyngstrom
Huntsman Cancer Institute, University of Utah,5126 West Daybreak Parkway
South Jordan, Utah 84009
1 trial
Huntsman Cancer Institute - University of Utah Health
Salt Lake City, Utah 84112
1 trial
NCT04996875(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Contact: Cogent Biosciences, Inc.
Huntsman Cancer Institute - Univ of Utah Health
Salt Lake City, Utah 84112
1 trial
The Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
The University of Utah - Huntsman Cancer Institute (HCI)
Salt Lake City, Utah 84112
1 trial
University of Utah Health Huntsman Cancer Center
Salt Lake City, Utah 84112
1 trial
NCT05986851Azeliragon in MGMT Unmethylated Glioblastoma
University of Utah-Huntsman Cancer Institute_Investigational Site Number 84035
Salt Lake City, Utah 84112
1 trial
University of Utah, Huntsman Cancer Institute (Site 0012)
Salt Lake City, Utah 84112
1 trial
University of Utah, Huntsman Cancer Institute (Site 0056)
Salt Lake City, Utah 84112
1 trial
University of Utah, Huntsman Cancer Institute (Site 0122)
Salt Lake City, Utah 84112
1 trial
University of Utah, Huntsman Cancer Institute (Site 0810)
Salt Lake City, Utah 84112
1 trial
Contact: Study Coordinator
University of Utah, Huntsman Cancer Institute (Site 1855)
Salt Lake City, Utah 84112-5550
1 trial
Univ. of Utah / Huntsman Cancer Center
Salt Lake City, Utah 84112
1 trial
Utah University School of Medicine/Huntsman Cancer Institute
Salt Lake City, Utah 84112
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer119 works · 51 trials
- Melanoma68 works · 53 trials
- Multiple myeloma43 works · 45 trials
- Kidney cancer40 works · 19 trials
- Hodgkin lymphoma37 works · 7 trials
- Ovarian cancer33 works · 21 trials
- Bladder cancer31 works · 33 trials
- Sarcoma22 works · 24 trials
- Myeloproliferative neoplasms22 works · 22 trials
- Neuroendocrine tumours22 works · 22 trials
- Chronic lymphocytic leukaemia14 works · 23 trials
- Acute lymphoblastic leukaemia13 works · 16 trials
- Childhood cancers13 works · 43 trials
- Diffuse large B-cell lymphoma12 works · 25 trials
- Meningioma9 works · 3 trials
- Mantle cell lymphoma9 works · 10 trials
- Follicular lymphoma7 works · 16 trials
Institution data: ROR 03v7tx966 (CC0-1.0)Updated 15 Nov 2026